Skip to main content

ACR 2022 Tweet by Patricia Harkins

View on
Sarilumab in GC resistant PMR
🔥SAPHYR🔥

👉Arm 1- sar 200mg Q2W + 14wk GC
👉 Arm 2- PBO Q2W + 52wk GC

🌟RESULTS🌟
💪🏻 Arm 1 - PMR symp + signs ⬇️ wk 2 with continued improvement until wk 52

🌟Arm 1- ⬇️ chance flare post achieving remission

#ACR22 @RheumNow
Image from Patricia Harkins’s tweet
×